Abstract
We report a case of a young male with chronic phase CML who despite achieving an excellent response to dasatinib therapy, developed isolated CNS blast crisis even though this tyrosine kinase inhibitor is the only one reported to cross the blood brain barrier.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have